Prevalence of airflow obstruction in smokers and never-smokers in Switzerland

European Respiratory Journal

Volumn 36, Issue 6, 2010, Pages 1259-1269

  Bridevaux, P O ^a   Probst Hensch, N M ^b   Schindler, C ^b   Curjuric, I ^b   Felber Dietrich, D ^b   Braendli, O ^c   Brutsche, M ^d   Burdet, L ^e   Frey, M ^f   Gerbase, M W ^a   Ackermann Liebrich, U ^b   Pons, M ^g   Tschopp, J M ^h   Rochat, T ^a   Russi, E W ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d CANTONAL HOSPITAL AARAU   (Switzerland)

^e Hopital Intercantonal de la Broye   (Switzerland)

^f Klinik Barmelweid   (Switzerland)

^g REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^h Centre Valaisan de Pneumologie   (Switzerland)

Author keywords

Asthma; Bronchial hyperreactivity; Chronic obstructive pulmonary disease; Population study; Sex differences; Smoking

Indexed keywords

METHACHOLINE;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; ATOPY; BRONCHUS HYPERREACTIVITY; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; EXPOSURE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY CARE; RISK FACTOR; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SHORT FORM 36; SMOKING; SOCIAL STATUS; SWITZERLAND;

ADULT; AGE FACTORS; AGED; AIRWAY OBSTRUCTION; ASTHMA; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING; SWITZERLAND;

EID: 78649745984     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00004110     Document Type: Article

References (45)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.
2. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 188-207.
3. Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28: 523-532. (Pubitemid 44794666)
4. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-750.
5. Celli BR, Halbert RJ, Nordyke RJ, et al. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. Am J Med 2005; 118: 1364-1372. (Pubitemid 41832329)
6. Lamprecht B, Schirnhofer L, Kaiser B, et al. Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study. Respir Med 2008; 102: 1833-1838.
7. Organisation for Economic Co-operation and Development (OECD) WHOW. OECD reviews of health systems: Switzerland. Paris, OECD Publishing, 2006.
8. Ackermann-Liebrich U, Kuna-Dibbert B, Probst-Hensch NM, et al. Follow-up of the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991-2003: methods and characterization of participants. Soz Praventivmed 2005; 50: 245-263.
9. Martin BW, Ackermann-Liebrich U, Leuenberger P, et al. SAPALDIA: methods and participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung Diseases in Adults. Soz Praventivmed 1997; 42: 67-84.
10. Brandli O, Schindler C, Kunzli N, et al. Lung function in healthy never smoking adults: reference values and lower limits of normal of a Swiss population. Thorax 1996; 51: 277-283. (Pubitemid 26086472)
11. de Marco R, Accordini S, Anto JM, et al. Long-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European community respiratory health survey. Am J Respir Crit Care Med 2009; 180: 956-963.
12. Bridevaux PO, Gerbase MW, Probst-Hensch NM, et al. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 2008; 63: 768-774.
13. Bridevaux PO. Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD. Eur Respir J 2009; 34: 332-339.
14. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5-40.
15. Miravitlles M, Soriano JB, Garcia-Rio F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64: 863-868.
16. Hegewald MJ, Crapo RO. Socioeconomic status and lung function. Chest 2007; 132: 1608-1614.
17. Lindberg A, Larsson LG, Ronmark E, et al. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms. COPD 2007; 4: 5-13. (Pubitemid 46348289)
18. Coultas DB, Mapel D, Gagnon R, et al. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001; 164: 372-377. (Pubitemid 32778201)
19. Whittemore AS, Perlin SA, DiCiccio Y. Chronic obstructive pulmonary disease in lifelong nonsmokers: results from NHANES. Am J Pub Health 1995; 85: 702-706.
20. Pena VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000; 118: 981-989.
21. Birring SS, Brightling CE, Bradding P, et al. Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. Am J Respir Crit Care Med 2002; 166: 1078-1083. (Pubitemid 35178705)
22. Centers for Disease Control and Prevention, Cigarette smoking among adults - United States, 2007. MMWR Morb Mortal Wkly Rep 2008; 57: 1221-1226.
23. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374: 733-743.
24. Kunzli N, Bridevaux PO, Liu LJ, et al. Traffic-related air pollution correlates with adult-onset asthma among never-smokers. Thorax 2009; 64: 664-670.
25. Schindler C, Keidel D, Gerbase MW, et al. Improvements in PM10 exposure and reduced rates of respiratory symptoms in a cohort of Swiss adults (SAPALDIA). Am J Respir Crit Care Med 2009; 179: 579-587.
26. Downs SH, Schindler C, Liu LJ, et al. Reduced exposure to PM10 and attenuated age-related decline in lung function. N Engl J Med 2007; 357: 2338-2347.
27. Bridevaux PO, Cornuz J, Gaspoz JM, et al. Secondhand smoke and health-related quality of life in never smokers: results from the SAPALDIA cohort study 2. Arch Int Med 2007; 167: 2516-2523. (Pubitemid 350254913)
28. Behrendt CE. Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest 2005; 128: 1239-1244.
29. Yin P, Jiang CQ, Cheng KK, et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet 2007; 370: 751-757. (Pubitemid 47320799)
30. Zhou Y, Wang C, Yao W, et al. COPD in Chinese nonsmokers. Eur Respir J 2009; 33: 509-518.
31. Brutsche MH, Downs SH, Schindler C, et al. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study. Thorax 2006; 61: 671-677. (Pubitemid 44211773)
32. Silva GE, Sherrill DL, Guerra S, et al. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004; 126: 59-65. (Pubitemid 38943118)
33. Orie NG, Slutter HJ, de Vries K, et al. [Chronic nonspecific respiratory diseases]. Ned Tijdschr Geneesk 1961; 105: 2136-2139.
34. Hunninghake GM, Cho MH, Tesfaigzi Y, et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med 2009; 361: 2599-2608.
35. Juul K, Tybjaerg-Hansen A, Marklund S, et al. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 858-864.
36. van Schayck CP, van Der Heijden FM, van Den Boom G, et al. Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project. Thorax 2000; 55: 562-565.
37. Hospers JJ, Schouten JP, Weiss ST, et al. Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample. Am J Respir Crit Care Med 1999; 160: 1869-1874.
38. Vonk JM, Jongepier H, Panhuysen CI, et al. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003; 58: 322-327.
39. Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994; 150: 629-634.
40. Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 680-685. (Pubitemid 34971850)
41. Turner MC, Chen Y, Krewski D, et al. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 2007; 176: 285-290.
42. Young RP, Hopkins R, Eaton TE. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J 2007; 30: 616-622.
43. Federal Statistical Office SC. Swiss Health Survey 2007. Neuchatel, OFS, 2007.
44. Johannessen A, Omenaas ER, Bakke PS, et al. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005; 60: 842-847.
45. Perez-Padilla R, Hallal PC, Vazquez-Garcia JC, et al. Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD 2007; 4: 113-120.